Exchange: NASDAQ·Updated 07:30 PM EDT
MNKD logo

MNKD Mannkind Corp

$4.03
$0.10
(2.52%)
Today
Closed $4.06
$0.0286
(0.70%)
After Hours
EarningsNov 4
Mkt Cap$1.27B
Vol2.81M

About MNKD

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.
30

Bearish Sentiment

How do you feel about MNKD?

Advertisement|Remove ads.